NASDAQ · PNTGHealthcareHealth Services

The Pennant Group financials

$40.50−0.98%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
FY24
Dec 31
FY23
Dec 31
FY22
Dec 31
FY21
Dec 31
FY20
Dec 31
FY19
Dec 31
Revenue$947.7M$695.2M$544.9M$473.2M$439.7M$391.0M$338.5M
Gross profit$179.2M$136.8M$106.8M$96.6M$89.5M$94.1M$79.6M
Gross margin18.9%19.7%19.6%20.4%20.3%24.1%23.5%
Operating income$50.9M$37.4M$25.2M$19.7M$7.6M$18.9M$5.7M
Net income$29.6M$22.6M$13.4M$6.6M$2.7M$15.7M$3.2M
Net margin3.1%3.2%2.5%1.4%0.6%4.0%0.9%
Diluted EPS$0.84$0.70$0.44$0.22$0.09$0.52$0.11
EBITDA$59.4M$43.6M$30.4M$24.6M$12.3M$23.6M$9.5M
Operating cash flow$48.3M$39.3M$33.1M$9.0M-$18.2M$50.2M$9.6M
Free cash flow$36.3M$30.3M$25.0M-$5.1M-$24.5M$43.0M$2.8M
Diluted shares35.3M32.0M30.2M30.2M30.6M30.2M29.6M

Balance sheet

Period endDec 31Dec 31Dec 31Dec 31Dec 31Dec 31
Cash & equivalents$17.0M$24.2M$6.1M$2.1M$5.2M$43.0K
Short-term investments$0.00$0.00$0.00$0.00——
Total debt$173.8M$0.00$63.9M$62.9M$51.4M$8.3M
Total assets$968.2M$679.5M$539.7M$512.1M$530.3M$507.0M
Total liabilities$593.9M$367.6M$394.2M$386.5M$416.1M$405.8M
Shareholders' equity$374.3M$312.0M$145.5M$125.7M$114.2M$101.2M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology